Free Trial
→ Silicon Valley Gold Rush (From Stansberry Research) (Ad) Free ARTV Stock Alerts

Artiva Biotherapeutics (ARTV) Institutional Ownership

Artiva Biotherapeutics logo
$1.64 +0.06 (+3.46%)
As of 07/3/2025 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Artiva Biotherapeutics (NASDAQ:ARTV)

Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$179.75M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$1.05M
Get ARTV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ARTV Institutional Buying and Selling by Quarter

Artiva Biotherapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2025venBio Partners LLC1,198,975$3.60M2.9%-21.1%4.921%
5/12/2025Nuveen LLC47,892$144K0.0%N/A0.197%
5/9/2025Charles Schwab Investment Management Inc.54,881$165K0.0%+26.1%0.225%
2/17/2025Deutsche Bank AG21,423$216K0.0%N/A0.088%
2/17/2025Bank of America Corp DE10,817$109K0.0%-39.3%0.045%
2/17/2025BNP Paribas Financial Markets9,879$100K0.0%+262.1%0.041%
2/14/2025Northern Trust Corp117,112$1.18M0.0%+3.8%0.482%
2/13/2025Barclays PLC24,161$244K0.0%+23.2%0.099%
2/13/2025Wells Fargo & Company MN8,616$87K0.0%+64.0%0.035%
2/12/2025Geode Capital Management LLC315,758$3.18M0.0%+2.2%1.300%
2/12/2025Norges Bank30,000$302K0.0%N/A0.124%
2/12/2025JPMorgan Chase & Co.37,619$379K0.0%+250.7%0.155%
2/6/2025Charles Schwab Investment Management Inc.43,526$439K0.0%+8.0%0.179%
1/30/2025Rhumbline Advisers12,879$130K0.0%-13.1%0.053%
1/24/2025China Universal Asset Management Co. Ltd.5,150$52K0.0%N/A0.021%
12/26/2024JPMorgan Chase & Co.10,726$166K0.0%N/A0.044%
11/27/2024Franklin Resources Inc.520,301$7.44M0.0%N/A2.142%
11/19/2024Barclays PLC19,616$304K0.0%N/A0.081%
11/16/2024Geode Capital Management LLC308,930$4.77M0.0%N/A1.272%
11/15/2024Barclays PLC19,616$304K0.0%N/A0.081%
11/15/2024Wellington Management Group LLP194,108$2.91M0.0%N/A0.799%
11/15/2024State Street Corp86,559$1.34M0.0%N/A0.356%
11/15/2024Samsara BioCapital LLC291,666$4.51M0.9%N/A1.201%
11/15/2024RA Capital Management L.P.9,853,302$152.23M1.8%N/A40.565%
11/15/2024RTW Investments LP148,844$2.30M0.0%N/A0.613%
11/14/2024Acuta Capital Partners LLC44,000$680K0.6%N/A0.181%
11/14/2024MetLife Investment Management LLC8,733$135K0.0%N/A0.036%
11/13/2024BNP Paribas Financial Markets2,728$42K0.0%N/A0.011%
11/12/2024Charles Schwab Investment Management Inc.40,293$623K0.0%N/A0.166%
(Data available from 1/1/2016 forward)

ARTV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ARTV shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Artiva Biotherapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($152.23M), Franklin Resources Inc. ($7.44M), Samsara BioCapital LLC ($4.51M), venBio Partners LLC ($3.60M), Geode Capital Management LLC ($3.18M), Wellington Management Group LLP ($2.91M), and RTW Investments LP ($2.30M).Learn more on Artiva Biotherapeutics' institutional investors.

Which institutional investors have been buying Artiva Biotherapeutics' stock?

Of the 19 institutional investors that purchased Artiva Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($9.85M), Franklin Resources Inc. ($520.30K), Geode Capital Management LLC ($315.76K), Samsara BioCapital LLC ($291.67K), Wellington Management Group LLP ($194.11K), RTW Investments LP ($148.84K), and State Street Corp ($86.56K).

How much institutional buying is happening at Artiva Biotherapeutics?

Institutional investors have bought a total of 11,721,588 shares in the last 24 months. This purchase volume represents approximately $179.75M in transactions.

Which of Artiva Biotherapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Artiva Biotherapeutics stock in the last 24 months: venBio Partners LLC ($321.00K), Bank of America Corp DE ($7.00K), and Rhumbline Advisers ($1.95K).

How much institutional selling is happening at Artiva Biotherapeutics?

Institutional investors have sold a total of 329,947 shares in the last 24 months. This volume of shares sold represents approximately $1.05M in transactions.


Related Companies

This page (NASDAQ:ARTV) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Revenge
Elon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...
Altimetry | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
379 passengers walked away from this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Gold: Now legal tender in many states
The perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...
Stansberry Research | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored